Midgard Science

Neurix

Geneva, Switzerlandneurix.chFrom their website, Nov 2026

Work here? Claim this listing

About

Neurix develops human iPSC-based in vitro cellular and organoid models for drug discovery and neurotherapeutic research. It serves researchers working on brain diseases and preclinical compound testing from Geneva, Switzerland.

Services

  • Glioblastoma Invasion Model

    Glioblastoma-organoid assembloids used to assess drug efficiency on tumour growth, motility, and metastasis, and to test effects on healthy tissue using organoids.

  • Blood-Brain Barrier Model

    Transwell-based model seeded with iPSC-derived human brain microvascular endothelial cells to assess compound penetration efficiency.

  • Alzheimer's Disease Model

    Human organoid model with disease-specific readouts including morphology, protein aggregation, and beta-amyloid immunoreactivity.

  • Parkinson's Disease Model

    Human organoid model with disease-specific readouts including morphology, protein and alpha-synuclein aggregation.

  • Personalised Service

    Custom neural tissues from human stem cells, with bespoke disease models, assays, and in-depth omics analyses for drug discovery.

  • High throughput drug screening

    A personalised-service assay for screening compounds at higher throughput.

  • Lead compound validation

    A personalised-service method for validating lead compounds.

  • iPSCs differentiation

    Differentiation of induced pluripotent stem cells for personalised neural model development.

7 more services
  • Spheroid generation
  • 2D/3D imaging
  • 3D imaging
  • Immunohistochemistry/Immunofluorescence
  • Fluorescence-based assays
  • Flow cytometry
  • Genomics, Proteomics

Capabilities

Assays and studies
  • Flow cytometry
  • Compound screening
  • Drug efficiency testing
  • Compound penetration testing
  • Morphology readouts
  • Protein aggregation readouts
12 more
  • Alpha-synuclein aggregation
  • High throughput drug screening
  • Lead compound validation
  • 2D imaging
  • 3D imaging
  • Immunohistochemistry
  • Immunofluorescence
  • Genomics
  • Proteomics
  • Drug screening
  • Compound testing
  • Fluorescence-based assays
Scale and capacity
  • High throughput
  • Short-term compound testing
  • Long-term compound testing
  • Highly physiological human 3-dimensional tissues
Therapeutic areas
  • Glioblastoma
  • Blood-brain barrier
  • Alzheimer's disease
  • Parkinson's disease
  • Neurodegenerative diseases
  • Brain disorders
3 more
  • Neuroscience
  • Neurotherapeutic research
  • Neuro-oncology

Instruments and platforms

  • Flow cytometry

Modalities and species

Modalities
Cell therapy
Species and models
  • Human iPSCs
  • Human brain microvascular endothelial cells
  • iPSCs-derived neurons
  • Astrocytes
  • Oligodendrocytes
  • BMEC
5 more
  • Cell line-derived spheroids
  • Patient-derived spheroids
  • Human
  • iPSC-derived human brain microvascular endothelial cells
  • Cell line or patient-derived spheroids

Industries served

  • Biotechnology
  • Pharmaceuticals
  • Neuroscience
  • Drug discovery

Details

Founded
2011
Based in
Geneva, Switzerland
Serves
Worldwide, Europe
Phone
+41 22 379 46 43

Similar labs